Kilian, J.; Ozenil, M.; Millard, M.; Fürtös, D.; Maisetschläger, V.; Holzer, W.; Wadsak, W.; Hacker, M.; Langer, T.; Pichler, V.
Design, Synthesis, and Biological Evaluation of 4,4’-Difluorobenzhydrol Carbamates as Selective M1 Antagonists. Pharmaceuticals 2022, 15, 248.
https://doi.org/10.3390/ph15020248
AMA Style
Kilian J, Ozenil M, Millard M, Fürtös D, Maisetschläger V, Holzer W, Wadsak W, Hacker M, Langer T, Pichler V.
Design, Synthesis, and Biological Evaluation of 4,4’-Difluorobenzhydrol Carbamates as Selective M1 Antagonists. Pharmaceuticals. 2022; 15(2):248.
https://doi.org/10.3390/ph15020248
Chicago/Turabian Style
Kilian, Jonas, Marius Ozenil, Marlon Millard, Dorka Fürtös, Verena Maisetschläger, Wolfgang Holzer, Wolfgang Wadsak, Marcus Hacker, Thierry Langer, and Verena Pichler.
2022. "Design, Synthesis, and Biological Evaluation of 4,4’-Difluorobenzhydrol Carbamates as Selective M1 Antagonists" Pharmaceuticals 15, no. 2: 248.
https://doi.org/10.3390/ph15020248
APA Style
Kilian, J., Ozenil, M., Millard, M., Fürtös, D., Maisetschläger, V., Holzer, W., Wadsak, W., Hacker, M., Langer, T., & Pichler, V.
(2022). Design, Synthesis, and Biological Evaluation of 4,4’-Difluorobenzhydrol Carbamates as Selective M1 Antagonists. Pharmaceuticals, 15(2), 248.
https://doi.org/10.3390/ph15020248